Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Study Suggests Genetics Play Strong Role in Young Fibromyalgia Patients

Vanessa Caceres  |  Issue: March 2021  |  March 15, 2021

Implications

“The variability in fibromyalgia score for younger individuals, which is potentially more likely to be primary fibromyalgia, appears to be more driven by genetic factors shared across individuals than in older individuals,” the authors write. “Older individuals may have a greater contribution of environmental factors to pain, a greater diversity of conditions that increase pain, and/or more susceptibility towards nociceptive pain. … Overall, our results suggest that genetic studies of fibromyalgia might have differing results depending on the age of the participants.”

In the future, the inclusion of younger patients in GWAS or large candidate gene studies may be beneficial, the authors write. In the past, these studies have focused on patients older than 50 or have not reported age at all.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“If comprised of the same number of individuals, studies focusing on younger individuals with pain may have more power to detect disease-genetic variant associations than studies of older individuals,” says study author Laura J. Scott, MPH, PhD, research professor, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor. Large-scale population studies that include a wide range of ages may offer the most power, such as a GWAS from 2019 that identified 39 loci for multi-site chronic pain, she says.4

One study limitation is that the sample in the current study is not population based, the authors write. Those who were included were scheduled for surgery and were more likely to have pain.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Although the authors do not have other research planned in this area, it would be interesting to identify genetic determinants of pain that overlap with psychiatric disorders and those that appear to be independent of them, Dr. Scott says.


Vanessa Caceres is a medical writer in Bradenton, Fla.

References

  1. Dutta D, Brummett CM, Moser SE, et al. Heritability of the fibromyalgia phenotype varies by age. Arthritis Rheumatol. 2020 May;72(5):815–823.
  2. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010 May;62(5):600–610.
  3. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol. 2011 Jun ;38(6):1113–1122.
  4. Johnson KJA, Adams MJ, Nicholl BI, et al. Genome-wide association study of multisite chronic pain in UK Biobank. PLoS Genet. 2019 Jun 13;15(6):e1008164.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsPain SyndromesResearch Rheum Tagged with:Fibromyalgiagenetic risk

Related Articles

    Shortcomings and Promises of Genome-wide Association Studies

    February 3, 2012

    The outcomes of genome-wide association studies (GWAS) have not been what scientists expected, but researchers are developing new approaches to use revelatory GWAS information to identify genetic causal variants, predictors of treatment response, and future opportunities for genetic insight.

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Genome-Wide Association Studies of SLE

    February 12, 2011

    What do these studies tell us about disease mechanisms in lupus?

    Is Fibromyalgia Overdiagnosed?

    October 10, 2016

    Are too many patients diagnosed with fibromyalgia? The co-authors of one new study believe that close to 75% of patients who have received a clinical fibromyalgia diagnosis do not meet the 2010 Preliminary American College of Rheumatology (ACR) Criteria for Fibromyalgia.1 They say these patients are false-positive and may be taking treatments they don’t need….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences